Milupa GmbHJune 7, 2024

FDA 483 - Milupa GmbH - June 07, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Milupa GmbH

Record Details

An FDA inspection of Milupa GmbH in Fulda, Germany, revealed a repeat observation regarding the firm's infant formula manufacturing practices. The company failed to test each production aggregate of infant formula for nutrients in a nutrient premix, relying instead on supplier Certificates of Analysis. This deficiency indicates a potential quality control issue in ensuring product specifications are met.

Company: Milupa GmbH
Inspection Date: June 7, 2024
Product Type: Other
Office: Office of Biological Products Operations - Division I
People: Danny Tuntevski (Investigator)
Gale L. Glinecki (Investigator )

Open in Dashboard

ID · d402d244-a68c-4b2b-a599-34e8216d772e